Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables (2016 - 2025)

Historic Receivables for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $22.1 million.

  • Lifecore Biomedical, Inc. \De\'s Receivables rose 878.43% to $22.1 million in Q2 2025 from the same period last year, while for May 2025 it was $22.1 million, marking a year-over-year increase of 878.43%. This contributed to the annual value of $22.1 million for FY2025, which is 878.43% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Receivables is $22.1 million, which was up 878.43% from $22.3 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Receivables registered a high of $53.6 million during Q1 2022, and its lowest value of $20.0 million during Q3 2023.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Receivables had a median value of $35.8 million in 2022 and averaged $33.7 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Receivables plummeted by 5539.36% in 2023 and then surged by 6372.76% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Receivables stood at $40.1 million in 2021, then fell by 10.57% to $35.9 million in 2022, then plummeted by 37.72% to $22.3 million in 2023, then skyrocketed by 63.73% to $36.6 million in 2024, then crashed by 39.47% to $22.1 million in 2025.
  • Its Receivables was $22.1 million in Q2 2025, compared to $22.3 million in Q1 2025 and $36.6 million in Q4 2024.